These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 9140729)
1. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region. Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729 [TBL] [Abstract][Full Text] [Related]
2. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142 [TBL] [Abstract][Full Text] [Related]
3. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Sato K; Tsuchiya M; Saldanha J; Koishihara Y; Ohsugi Y; Kishimoto T; Bendig MM Cancer Res; 1993 Feb; 53(4):851-6. PubMed ID: 8428365 [TBL] [Abstract][Full Text] [Related]
4. Humanization of a chicken anti-IL-12 monoclonal antibody. Tsurushita N; Park M; Pakabunto K; Ong K; Avdalovic A; Fu H; Jia A; Vásquez M; Kumar S J Immunol Methods; 2004 Dec; 295(1-2):9-19. PubMed ID: 15627607 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody. Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393 [TBL] [Abstract][Full Text] [Related]
6. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity. Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338 [TBL] [Abstract][Full Text] [Related]
7. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides. Qin W; Feng J; Li Y; Lin Z; Shen B Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837 [TBL] [Abstract][Full Text] [Related]
8. Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling. Zhang W; Feng J; Li Y; Guo N; Shen B Mol Immunol; 2005 Aug; 42(12):1445-51. PubMed ID: 15950738 [TBL] [Abstract][Full Text] [Related]
9. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells. Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403 [TBL] [Abstract][Full Text] [Related]
10. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance. Polymenis M; Stollar BD J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-VH141 antibodies that specifically recognize the heavy chain variable region of, and are closely related to, MOPC141 myeloma protein whose VH gene belongs to VHQ52 family. Minami Y; Sakato N; Komori T; Kishimoto S; Sugiyama H Immunology; 1991 Apr; 72(4):464-70. PubMed ID: 1903762 [TBL] [Abstract][Full Text] [Related]
12. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465 [TBL] [Abstract][Full Text] [Related]
13. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains. Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801 [TBL] [Abstract][Full Text] [Related]
14. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells. Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071 [TBL] [Abstract][Full Text] [Related]
15. Molecular selection of human antibodies with an unconventional bacterial B cell antigen. Sasano M; Burton DR; Silverman GJ J Immunol; 1993 Nov; 151(10):5822-39. PubMed ID: 8228264 [TBL] [Abstract][Full Text] [Related]
16. Two Ig framework I epitopic specificities recognized by a rabbit antiserum and a monoclonal antibody to mouse VH chains. Black A; Padlan EA; Givol D; Morrison SL; Kabat EA J Immunol; 1990 Apr; 144(7):2620-6. PubMed ID: 1690771 [TBL] [Abstract][Full Text] [Related]
17. Guided selection of human antibody light chains against TAG-72 using a phage display chain shuffling approach. Kim SJ; Hong HJ J Microbiol; 2007 Dec; 45(6):572-7. PubMed ID: 18176543 [TBL] [Abstract][Full Text] [Related]
18. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody. Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725 [TBL] [Abstract][Full Text] [Related]
19. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303 [TBL] [Abstract][Full Text] [Related]
20. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier. Boado RJ; Zhang Y; Zhang Y; Pardridge WM Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]